Connection

HELEN PIWNICA-WORMS to Humans

This is a "connection" page, showing publications HELEN PIWNICA-WORMS has written about Humans.
Connection Strength

0.370
  1. Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast. Nat Commun. 2021 08 18; 12(1):5024.
    View in: PubMed
    Score: 0.015
  2. Pharmacologic profiling of patient-derived xenograft models of primary treatment-na?ve triple-negative breast cancer. Sci Rep. 2020 10 21; 10(1):17899.
    View in: PubMed
    Score: 0.014
  3. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med. 2019 04 17; 11(488).
    View in: PubMed
    Score: 0.013
  4. High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun. 2018 11 29; 9(1):5079.
    View in: PubMed
    Score: 0.013
  5. Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence. J Mammary Gland Biol Neoplasia. 2018 12; 23(4):191-205.
    View in: PubMed
    Score: 0.012
  6. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer. Breast Cancer Res. 2016 Jan 27; 18(1):13.
    View in: PubMed
    Score: 0.010
  7. Contribution of p53 to metastasis. Cancer Discov. 2014 Apr; 4(4):405-14.
    View in: PubMed
    Score: 0.009
  8. Phosphorylation of the E3 ubiquitin ligase RNF41 by the kinase Par-1b is required for epithelial cell polarity. J Cell Sci. 2014 Jan 15; 127(Pt 2):315-27.
    View in: PubMed
    Score: 0.009
  9. CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol. 2013 Jan; 33(2):213-26.
    View in: PubMed
    Score: 0.008
  10. Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest. 2012 Apr; 122(4):1541-52.
    View in: PubMed
    Score: 0.008
  11. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med. 2011 Feb; 17(2):88-96.
    View in: PubMed
    Score: 0.007
  12. A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. Cancer Chemother Pharmacol. 2011 Jun; 67(6):1225-37.
    View in: PubMed
    Score: 0.007
  13. Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction. Oncogene. 2010 Jun 10; 29(23):3324-34.
    View in: PubMed
    Score: 0.007
  14. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res. 2009 Mar 15; 69(6):2630-7.
    View in: PubMed
    Score: 0.006
  15. Phosphorylation of the Par-1 polarity kinase by protein kinase D regulates 14-3-3 binding and membrane association. Proc Natl Acad Sci U S A. 2008 Nov 25; 105(47):18378-83.
    View in: PubMed
    Score: 0.006
  16. Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379. Mol Cell Biol. 2008 Oct; 28(19):5874-85.
    View in: PubMed
    Score: 0.006
  17. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell. 2008 Jan; 13(1):36-47.
    View in: PubMed
    Score: 0.006
  18. The Par-1/MARK family of protein kinases: from polarity to metabolism. Cell Cycle. 2007 Aug 15; 6(16):1966-9.
    View in: PubMed
    Score: 0.006
  19. Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol Cell Biol. 2006 Oct; 26(20):7529-38.
    View in: PubMed
    Score: 0.005
  20. BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers. Cancer Discov. 2024 Aug 02; 14(8):1476-1495.
    View in: PubMed
    Score: 0.005
  21. Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem. 2004 Jul 30; 279(31):32046-54.
    View in: PubMed
    Score: 0.005
  22. Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr Biol. 2004 Apr 20; 14(8):736-41.
    View in: PubMed
    Score: 0.005
  23. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol. 2003 Nov; 23(21):7488-97.
    View in: PubMed
    Score: 0.004
  24. Cdc25A regulation: to destroy or not to destroy--is that the only question? Cell Cycle. 2003 Sep-Oct; 2(5):455-7.
    View in: PubMed
    Score: 0.004
  25. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol Cancer Res. 2003 Jun; 1(8):598-609.
    View in: PubMed
    Score: 0.004
  26. Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy. Invest New Drugs. 2023 Jun; 41(3):391-401.
    View in: PubMed
    Score: 0.004
  27. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci U S A. 2002 Nov 12; 99(23):14795-800.
    View in: PubMed
    Score: 0.004
  28. 14-3-3 binding regulates catalytic activity of human Wee1 kinase. Cell Growth Differ. 2001 Dec; 12(12):581-9.
    View in: PubMed
    Score: 0.004
  29. Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer. Br J Cancer. 2022 03; 126(4):615-627.
    View in: PubMed
    Score: 0.004
  30. Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer. Nat Commun. 2021 09 10; 12(1):5389.
    View in: PubMed
    Score: 0.004
  31. The G(2) DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem. 2001 Oct 05; 276(40):37166-77.
    View in: PubMed
    Score: 0.004
  32. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001 Jul; 21(13):4129-39.
    View in: PubMed
    Score: 0.004
  33. Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol. 2001 Jun; 21(12):3853-61.
    View in: PubMed
    Score: 0.004
  34. Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. Mol Cell Biol. 2001 May; 21(9):3206-19.
    View in: PubMed
    Score: 0.004
  35. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene. 2001 Apr 05; 20(15):1839-51.
    View in: PubMed
    Score: 0.004
  36. Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells. J Immunother Cancer. 2021 03; 9(3).
    View in: PubMed
    Score: 0.004
  37. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020 11 04; 22(1):121.
    View in: PubMed
    Score: 0.004
  38. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem. 2000 Feb 25; 275(8):5600-5.
    View in: PubMed
    Score: 0.003
  39. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing. Nat Commun. 2020 01 24; 11(1):486.
    View in: PubMed
    Score: 0.003
  40. Cell cycle. Fools rush in. Nature. 1999 Oct 07; 401(6753):535, 537.
    View in: PubMed
    Score: 0.003
  41. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
    View in: PubMed
    Score: 0.003
  42. Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet. Cell. 2019 08 22; 178(5):1115-1131.e15.
    View in: PubMed
    Score: 0.003
  43. 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers. Clin Cancer Res. 2019 09 15; 25(18):5702-5716.
    View in: PubMed
    Score: 0.003
  44. Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes. Mol Cell Biol. 1999 Jul; 19(7):5113-23.
    View in: PubMed
    Score: 0.003
  45. Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2019 08 15; 79(16):4211-4226.
    View in: PubMed
    Score: 0.003
  46. Ca2+-Stimulated AMPK-Dependent Phosphorylation of Exo1 Protects Stressed Replication Forks from Aberrant Resection. Mol Cell. 2019 06 20; 74(6):1123-1137.e6.
    View in: PubMed
    Score: 0.003
  47. BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1a activation. Proc Natl Acad Sci U S A. 2018 10 09; 115(41):E9600-E9609.
    View in: PubMed
    Score: 0.003
  48. Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. Mol Cell. 2018 08 16; 71(4):606-620.e7.
    View in: PubMed
    Score: 0.003
  49. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Rep. 2018 04 03; 23(1):213-226.e3.
    View in: PubMed
    Score: 0.003
  50. C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ. 1998 Mar; 9(3):197-208.
    View in: PubMed
    Score: 0.003
  51. CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition. Cancer Res. 2018 02 01; 78(3):781-797.
    View in: PubMed
    Score: 0.003
  52. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 1997 Sep 05; 277(5331):1501-5.
    View in: PubMed
    Score: 0.003
  53. CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib. Cancer Res. 2017 07 15; 77(14):3870-3884.
    View in: PubMed
    Score: 0.003
  54. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol Cell Biol. 1997 Feb; 17(2):571-83.
    View in: PubMed
    Score: 0.003
  55. Patient-derived xenograft (PDX) models in basic and translational breast cancer research. Cancer Metastasis Rev. 2016 12; 35(4):547-573.
    View in: PubMed
    Score: 0.003
  56. Reversible phosphorylation and mitotic control. J Lab Clin Med. 1996 Oct; 128(4):350-4.
    View in: PubMed
    Score: 0.003
  57. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth. Oncogene. 2016 11 17; 35(46):5977-5988.
    View in: PubMed
    Score: 0.003
  58. Identification of a 95-kDa WEE1-like tyrosine kinase in HeLa cells. Proc Natl Acad Sci U S A. 1995 Oct 10; 92(21):9638-42.
    View in: PubMed
    Score: 0.003
  59. Poly(ADP-ribose)-binding promotes Exo1 damage recruitment and suppresses its nuclease activities. DNA Repair (Amst). 2015 Nov; 35:106-15.
    View in: PubMed
    Score: 0.003
  60. Flap Endonuclease 1 Limits Telomere Fragility on the Leading Strand. J Biol Chem. 2015 Jun 12; 290(24):15133-45.
    View in: PubMed
    Score: 0.002
  61. 14-3-3 proteins restrain the Exo1 nuclease to prevent overresection. J Biol Chem. 2015 May 08; 290(19):12300-12.
    View in: PubMed
    Score: 0.002
  62. Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1. J Biol Chem. 2015 Apr 03; 290(14):9075-86.
    View in: PubMed
    Score: 0.002
  63. Purification of a serine kinase that associates with and phosphorylates human Cdc25C on serine 216. J Biol Chem. 1994 Dec 02; 269(48):30461-9.
    View in: PubMed
    Score: 0.002
  64. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol. 1994 Dec; 14(12):8420-31.
    View in: PubMed
    Score: 0.002
  65. Cell cycle regulation of the p34cdc2 inhibitory kinases. Mol Biol Cell. 1994 Sep; 5(9):989-1001.
    View in: PubMed
    Score: 0.002
  66. A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J. 1993 May; 12(5):1947-54.
    View in: PubMed
    Score: 0.002
  67. Mechanisms of p34cdc2 regulation. Mol Cell Biol. 1993 Mar; 13(3):1675-85.
    View in: PubMed
    Score: 0.002
  68. A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer. Breast Cancer Res Treat. 2013 Jan; 137(2):483-92.
    View in: PubMed
    Score: 0.002
  69. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science. 1992 Sep 25; 257(5078):1955-7.
    View in: PubMed
    Score: 0.002
  70. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012 Jun 10; 486(7403):353-60.
    View in: PubMed
    Score: 0.002
  71. Okazaki fragment processing-independent role for human Dna2 enzyme during DNA replication. J Biol Chem. 2012 Jun 22; 287(26):21980-91.
    View in: PubMed
    Score: 0.002
  72. Cyclin promotes the tyrosine phosphorylation of p34cdc2 in a wee1+ dependent manner. EMBO J. 1991 May; 10(5):1255-63.
    View in: PubMed
    Score: 0.002
  73. p107wee1 is a serine/threonine and tyrosine kinase that promotes the tyrosine phosphorylation of the cyclin/p34cdc2 complex. Cold Spring Harb Symp Quant Biol. 1991; 56:567-76.
    View in: PubMed
    Score: 0.002
  74. Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis. PLoS Pathog. 2010 Mar 19; 6(3):e1000814.
    View in: PubMed
    Score: 0.002
  75. The polarity protein Par1b/EMK/MARK2 regulates T cell receptor-induced microtubule-organizing center polarization. J Immunol. 2009 Jul 15; 183(2):1215-21.
    View in: PubMed
    Score: 0.002
  76. Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit. J Cell Biol. 2008 Apr 07; 181(1):89-103.
    View in: PubMed
    Score: 0.002
  77. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe. 2007 Jun 14; 1(4):275-86.
    View in: PubMed
    Score: 0.001
  78. Identification of protein phosphorylation sites within Ser/Thr-rich cluster domains using site-directed mutagenesis and hybrid linear quadrupole ion trap Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom. 2007; 21(21):3443-51.
    View in: PubMed
    Score: 0.001
  79. New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol Cell Biol. 2006 Oct; 26(19):7086-102.
    View in: PubMed
    Score: 0.001
  80. Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity. Proc Natl Acad Sci U S A. 2006 May 30; 103(22):8534-9.
    View in: PubMed
    Score: 0.001
  81. Accurate mass-driven analysis for the characterization of protein phosphorylation. Study of the human Chk2 protein kinase. Anal Chem. 2006 Apr 01; 78(7):2171-81.
    View in: PubMed
    Score: 0.001
  82. Replication of the vesicular stomatitis virus genome in permissive and nonpermissive host cells. J Biol Chem. 1985 Sep 05; 260(19):10503-11.
    View in: PubMed
    Score: 0.001
  83. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell. 2005 Feb; 7(2):193-204.
    View in: PubMed
    Score: 0.001
  84. Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci U S A. 2004 Aug 17; 101(33):12288-93.
    View in: PubMed
    Score: 0.001
  85. Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol. 2003 Jun; 5(6):545-51.
    View in: PubMed
    Score: 0.001
  86. Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6961-6.
    View in: PubMed
    Score: 0.001
  87. Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):1990-5.
    View in: PubMed
    Score: 0.001
  88. The human decatenation checkpoint. Proc Natl Acad Sci U S A. 2001 Oct 09; 98(21):12044-9.
    View in: PubMed
    Score: 0.001
  89. New perspectives on Raf-1: the involvement of p21ras in the activation of Raf-1 and a potential role for Raf-1 in events occurring later in the cell cycle. Cold Spring Harb Symp Quant Biol. 1991; 56:251-63.
    View in: PubMed
    Score: 0.001
  90. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 2000 Nov 01; 60(21):5934-6.
    View in: PubMed
    Score: 0.001
  91. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc Natl Acad Sci U S A. 1999 Mar 30; 96(7):3745-50.
    View in: PubMed
    Score: 0.001
  92. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol. 1998 Sep; 18(9):5229-38.
    View in: PubMed
    Score: 0.001
  93. Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell. 1998 May 15; 93(4):617-25.
    View in: PubMed
    Score: 0.001
  94. Serine phosphorylation-dependent association of the band 4.1-related protein-tyrosine phosphatase PTPH1 with 14-3-3beta protein. J Biol Chem. 1997 Oct 24; 272(43):27281-7.
    View in: PubMed
    Score: 0.001
  95. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 1997 Sep 05; 277(5331):1497-501.
    View in: PubMed
    Score: 0.001
  96. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol. 1994 Nov 01; 4(11):973-82.
    View in: PubMed
    Score: 0.001
  97. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993 Dec 28; 336(3):417-24.
    View in: PubMed
    Score: 0.001
  98. Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex. J Biol Chem. 1992 Sep 05; 267(25):18040-6.
    View in: PubMed
    Score: 0.001
  99. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J Biol Chem. 1992 Mar 15; 267(8):5408-15.
    View in: PubMed
    Score: 0.000
  100. cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science. 1990 Nov 09; 250(4982):805-8.
    View in: PubMed
    Score: 0.000
  101. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 1989 Sep 22; 58(6):1085-95.
    View in: PubMed
    Score: 0.000
  102. Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity. Proc Natl Acad Sci U S A. 1986 Jul; 83(14):5131-5.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.